| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jan 3, 2022 | Jan 4, 2022 | Editas Medicine, Inc. | CEO | Sell | 40.0 | -18,252 | -19.39% | ✗ | $492K |
| Oct 18, 2021 | Oct 20, 2021 | Editas Medicine, Inc. | CEO | Sell | 40.0 | -13,805 | -19.31% | ✗ | $525K |
| Mar 2, 2021 | Mar 4, 2021 | Editas Medicine, Inc. | CEO | Buy | 100.0 | +25,000 | 250.00% | ✗ | $1.2M |
| May 18, 2018 | May 22, 2018 | Editas Medicine, Inc. | Director | Buy | 97.5 | +10,000 | 100.00% | ✗ | $380.3K |
| Nov 13, 2017 | Nov 14, 2017 | INSULET CORP | Director | Buy | 95.0 | +2,500 | 80.70% | ✗ | $168.6K |
| Nov 14, 2014 | Nov 17, 2014 | REVVITY, INC. | Director | Sell | 20.0 | -8,892 | -16.33% | ✗ | $388.8K |
| Feb 7, 2014 | Feb 11, 2014 | REVVITY, INC. | Director | Sell | 20.0 | -12,951 | -23.07% | ✗ | $566.3K |
| Apr 30, 2013 | May 2, 2013 | REVVITY, INC. | Director | Sell | 22.5 | -3,177 | -6.85% | ✗ | $195.2K |
| Feb 21, 2012 | Feb 22, 2012 | REVVITY, INC. | Director | Sell | 22.5 | -5,865 | -13.90% | ✗ | $157.5K |